ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,079Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 609

$1.01M Total Retail Price of All Prescriptions

Rank: 20 out of 609

657 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 657 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

7% of this provider’s 657 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 12,499 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 36%.

Prescription Price

$63 was the average price of a prescription from this provider, compared to $117 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
WARFARIN SODIUM 665 527 1 8
FUROSEMIDE 608 503 2 4
LEVOTHYROXINE SODIUM 592 439 3 7
METOPROLOL TARTRATE 516 379 4 9
SIMVASTATIN 458 373 5 1
POTASSIUM CHLORIDE 340 305 6 40
ENALAPRIL MALEATE 339 263 7 32
OXYCODONE-ACETAMINOPHEN 321 245 S2 8 44
OMEPRAZOLE 305 250 9 3
AMLODIPINE BESYLATE 277 216 10 2
LOVASTATIN 255 156 11 199
CIPROFLOXACIN HCL 207 154 12 42
COUMADIN 206 185 13 163
ZOLPIDEM TARTRATE 203 144 14 18
CARVEDILOL 202 172 15 14
GABAPENTIN 197 170 16 21
CRESTOR 187 127 17 16
FAMOTIDINE 181 161 18 50
DIGOXIN 173 140 19 33
FENTANYL 168 117 S2 20 66
DONEPEZIL HCL 162 158 21 22
LISINOPRIL 159 103 22 12
SERTRALINE HCL 159 138 22 61
NITROGLYCERIN PATCH 158 153 24 120
METFORMIN HCL 155 122 25 10
LANTUS 152 135 26 82
CITALOPRAM HBR 151 141 27 112
GLIPIZIDE 146 118 28 169
CLOPIDOGREL 144 113 29 17
METOPROLOL SUCCINATE 141 108 30 5
IPRATROPIUM-ALBUTEROL 137 103 31 173
TAMSULOSIN HCL 133 118 32 11
MIRTAZAPINE 133 127 32 58
ALLOPURINOL 130 108 34 75
HYDROCODONE-ACETAMINOPHEN 119 88 S3 35 30
DIOVAN 118 87 36 15
ESCITALOPRAM OXALATE 107 100 37 91
LACTULOSE 101 58 38 109
TRAMADOL HCL 99 96 39 39
NYSTATIN 97 90 40 260
PLAVIX 97 80 40 25
DOXYCYCLINE HYCLATE 95 51 42 204
NOVOLIN R 82 77 43 325
ISOSORBIDE MONONITRATE ER 81 74 44 62
LYRICA 81 58 44 90
POLYETHYLENE GLYCOL 3350 80 58 46 99
NAMENDA 79 78 47 36
TRICOR 77 62 48 130
PANTOPRAZOLE SODIUM 76 58 49 29
AZITHROMYCIN 72 56 50 67
ADVAIR DISKUS 70 62 51 28
CEFUROXIME 68 43 52 251
METHYLPREDNISOLONE 68 46 52 145
SPIRONOLACTONE 67 31 54 105
ATENOLOL 65 36 55 27
PROAIR HFA 63 34 56 57
TRAZODONE HCL 63 45 56 113
CARBIDOPA-LEVODOPA 62 61 58 49
CEPHALEXIN 62 37 58 196
SPIRIVA 61 38 60 43
LEVOFLOXACIN 60 39 61 127
CYMBALTA 60 35 61 76
LIDODERM 59 58 63 81
TORSEMIDE 58 51 64 124
NEXIUM 58 36 64 13
OXYBUTYNIN CHLORIDE ER 58 52 64 114
RAMIPRIL 57 43 67 46
FINASTERIDE 57 49 67 37
HUMALOG 57 35 67 117
DILTIAZEM 24HR CD 56 43 70 154
HYDROCHLOROTHIAZIDE 56 50 70 20
SANTYL 56 48 70 186
FENOFIBRATE 54 35 73 143
KLOR-CON 10 52 31 74 288
HUMULIN R 51 31 75 480
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.